Cargando…
Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility
BACKGROUND: Pharmacotherapy of epilepsy including antiepileptic drugs (AEDs) is one of the main treatment approaches. As a biological target, sodium channels (Nav channels) and glutamate receptor genes are playing a major role in the etiology and treatment of epilepsy. OBJECTIVE: This study aims to...
Autores principales: | AL-Eitan, Laith N., Al-Dalalah, Islam M., Aljamal, Hanan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598501/ https://www.ncbi.nlm.nih.gov/pubmed/31297029 http://dx.doi.org/10.1016/j.jsps.2019.04.009 |
Ejemplares similares
-
Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients
por: AL-Eitan, Laith N, et al.
Publicado: (2019) -
The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy
por: AL-Eitan, Laith N., et al.
Publicado: (2018) -
SCN1A polymorphisms influence the antiepileptic drugs responsiveness in Jordanian epileptic patients
por: Abduljabbar, Rami, et al.
Publicado: (2023) -
Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study
por: AL-Eitan, Laith N, et al.
Publicado: (2019) -
Association Between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and Responsiveness to Antiepileptic Drugs: A Meta-Analysis
por: Li, Mengmeng, et al.
Publicado: (2021)